NCT04290325

HMPL-453 in Advanced Malignant Mesothelioma

A Phase II, Single Arm, Multicenter and Open Labelstudy Evaluating the Efficacy, Safety and Pharmacokinetics of HMPL-453 in Patient With Advanced Malignant Mesothelioma

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 27 (estimated)
• Sponsor: Hutchison Medipharma Limited · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a phase II, single arm, multicenter and open-label study to evaluate the efficacy, safety and pharmacokinetic of HMPL-453 in patient with advanced Malignant Mesothelioma

Detailed description

Histologically confirmed patients with advanced malignant mesothelioma that who was failure of the first -line systemic therapy

Conditions

• Advanced Malignant Mesothelioma

Interventions

Type	Name	Description
DRUG	HMPL-453	HMPL-453 tablet

Timeline

• Start date: 2019-12-30
• Primary completion: 2022-11-30
• Completion: 2023-03-17
• First posted: 2020-02-28
• Last updated: 2020-06-16

Locations

1 site across 1 country: China